Calibr-Skaggs Institute for Innovative Medicines
La Jolla, California, United States
Purpose
to accelerate the early clinical development of novel SARS-CoV-2 Mpro antiviral drug
Division
Global Health
Date
October 2021
Region Served
GLOBAL
Committed amount
$6,260,267
Grant topic
Discovery and Translational Sciences, Research and Learning Opportunities
Duration (months)
6
Grantee location
La Jolla, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.